| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 695.18M | 700.42M | 560.57M | 413.86M | 326.77M |
| Gross Profit | 475.17M | 437.36M | 251.78M | 173.19M | 94.68M |
| EBITDA | 32.79M | 46.81M | 75.11M | 65.51M | 49.22M |
| Net Income | 44.66M | 44.44M | 51.13M | 44.15M | 31.83M |
Balance Sheet | |||||
| Total Assets | 925.75M | 907.75M | 565.85M | 561.98M | 518.52M |
| Cash, Cash Equivalents and Short-Term Investments | 398.05M | 456.25M | 315.55M | 297.27M | 177.90M |
| Total Debt | 96.67M | 46.08M | 46.17M | 39.93M | 40.70M |
| Total Liabilities | 247.40M | 248.53M | 200.54M | 250.56M | 241.60M |
| Stockholders Equity | 678.52M | 659.40M | 365.41M | 306.73M | 273.17M |
Cash Flow | |||||
| Free Cash Flow | 97.27M | 40.77M | 10.13M | 15.06M | 46.11M |
| Operating Cash Flow | 91.16M | 45.25M | 26.12M | 30.28M | 57.59M |
| Investing Cash Flow | -130.06M | -37.76M | -11.80M | 80.99M | -36.73M |
| Financing Cash Flow | 0.00 | 245.55M | 4.68M | -18.20M | 6.28M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | HK$4.39B | 6.69 | 11.16% | 13.26% | -3.80% | -27.62% | |
74 Outperform | HK$5.10B | 1.95 | 15.47% | 8.39% | 2.85% | -33.83% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
59 Neutral | HK$2.25B | 381.25 | 6.68% | ― | ― | ― | |
59 Neutral | HK$1.84B | 34.32 | 2.32% | 3.20% | 13.35% | -38.32% | |
44 Neutral | HK$399.84M | 11.29 | 2.55% | 1.22% | 14.93% | 19.84% | |
42 Neutral | HK$334.00M | ― | -0.14% | ― | 23.71% | -112.50% |